You are here: HomeSolutionsIndustriesConsumer Health
print my pages

Country Report

Consumer Health in Macedonia

May 2012

Price: US$2,400

About this Report

EXECUTIVE SUMMARY

Consumer health growth strong as self-medication on the rise

2011 was yet another year in which consumer health experienced strong growth. In fact this growth continued throughout the review period, regardless of the recent economic and financial woes as a result of the possibly largest global recession in post WWII Europe. Consumers in Macedonia increasingly take charge of their own health following global trends. Self-medication was strong, underpinned by intensive advertising of OTC remedies. In an effort to avoid costly and time-consuming visits to hospitals and examinations by physicians, consumers tried to make the most of OTC products through self-medicating, thus supporting the overall growth of consumer health in Macedonia.

Economic downturn has no impact on consumer health growth

The recent global recession had virtually no impact on overall consumer health in Macedonia. However, consumers did struggle to obtain cheaper alternatives to counter the impact of the economic downturn towards the end of the review period. Nonetheless, consumer health in Macedonia remained largely unaffected. Macedonia benefits from its geographic location – close to the Mediterranean and part of the Balkans eco-system rich in ingredients with exceptional nutritional value. As a result Macedonians tend to consume health care products only on an as-needed basis. Because fresh fruit, vegetables and herbs in their natural form have become much more expensive, nutrition became very expensive too, so the dietary and nutritional choices Macedonians make nowadays are much poorer and lead to an increased incidence of self-medication.

Domestic company leads, but international companies dominate

Domestic company Alkaloid AD remained the key player in Macedonia’s consumer health market in 2011. It was followed by several prominent regional and international companies which have maintained and some even improved their shares in 2011. All key players in consumer health have invested heavily in marketing and advertising in recent years. It is highly likely that this trend will continue over the forecast period, with the same if not even greater intensity. International companies such as Krka, Bayer, Bristol-Myers Squibb, Lek and Krüger are among the leading players in the consumer health environment.

Chemists/pharmacies represent dominant distribution channel

The vast majority of OTC products are normally sold through chemists/pharmacies, underpinned by the prevailing notion that this is the only channel which can offer expert advice. The other reason is the high level of government intervention and regulation related to selling products which affect the health of the general public. This landscape is unlikely to change significantly over the forecast period, although some consumer health products are available through other distribution channels besides chemists/pharmacies. In 2011 there were no parapharmacies/drugstores in Macedonia, and there seems to be little private sector interest in changing this. Chemists/pharmacies offer the widest range of products across most if not all consumer health categories.

Forecast period growth slower but still strong

Over the forecast period, consumer health is expected to slow down its growth compared with the growth experienced over the review period. Self-medication’s continued strong growth throughout the review period influenced positively the growth of overall consumer health. However, increased availability of “positive list” prescription medicines which can be used to substitute some OTC products will have a direct impact on the overall growth rate of consumer health over the forecast period, moderately slowing it down. However, future prospects for consumer health are still strong and unlike some of the other consumer market segments it is expected to confidently grow with more innovation in self-medication and intensive advertising efforts by the lead market players, both domestic and international.


Samples (FAQs about samples):

doc_pdf.png Sample Consumer Health Market Research Report

doc_excel_table.png Sample Consumer Health Data

Delivery: Files are delivered directly into your account within a few minutes of purchase.

Overview

Discover the latest market trends and uncover sources of future market growth for the Consumer Health industry in Macedonia with research from Euromonitor's team of in-country analysts.

Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.

If you're in the Consumer Health industry in Macedonia, our research will save you time and money while empowering you to make informed, profitable decisions.

When you purchase this report, you also get the data and the content from these category reports in Macedonia for free:

The Consumer Health in Macedonia market research report includes:

  • Analysis of key supply-side and demand trends
  • Detailed segmentation of international and local products
  • Historic volumes and values, company and brand market shares
  • Five year forecasts of market trends and market growth  
  • Robust and transparent market research methodology, conducted in-country

Our market research reports answer questions such as:

  • What is the market size of Consumer Health in Macedonia?
  • What are the major brands in Macedonia?
  • What are the main trends in OTC Healthcare?

Why buy this report?

  • Gain competitive intelligence about market leaders
  • Track key industry trends, opportunities and threats
  • Inform your marketing, brand, strategy and market development, sales and supply functions

This industry report originates from Passport, our Consumer Health market research database.

Table of Contents

Table of Contents

Consumer Health in Macedonia - Industry Overview

EXECUTIVE SUMMARY

Consumer health growth strong as self-medication on the rise

Economic downturn has no impact on consumer health growth

Domestic company leads, but international companies dominate

Chemists/pharmacies represent dominant distribution channel

Forecast period growth slower but still strong

KEY TRENDS AND DEVELOPMENTS

High youth unemployment affects consumer health

Macedonia’s rapid urbanisation and its impact on consumer health

Retail formats continue to expand and diversify

The future of smoking in Macedonia

Sedentary lifestyles and poor diet choices boost weight management

MARKET INDICATORS

  • Table 1 Consumer Expenditure on Health Goods and Medical Services 2006-2011
  • Table 2 Life Expectancy at Birth 2006-2011

MARKET DATA

  • Table 3 Sales of Consumer Health by Category: Value 2006-2011
  • Table 4 Sales of Consumer Health by Category: % Value Growth 2006-2011
  • Table 5 Consumer Health Company Shares 2007-2011
  • Table 6 Consumer Health Brand Shares 2008-2011
  • Table 7 Sales of Consumer Health by Distribution Format: % Analysis 2006-2011
  • Table 8 Sales of Consumer Health by Category and Distribution Format: % Analysis 2010
  • Table 9 Forecast Sales of Consumer Health by Category: Value 2011-2016
  • Table 10 Forecast Sales of Consumer Health by Category: % Value Growth 2011-2016

APPENDIX

OTC registration and classification

Vitamins and dietary supplements registration and classification

Self-medication/self-care and preventive medicine

Switches

SOURCES

  • Summary 1 Research Sources

Consumer Health in Macedonia - Company Profiles

Alkaloid AD in Consumer Health (Macedonia)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 4 Alkaloid AD: Competitive Position 2011

Galafarm dooel Skopje in Consumer Health (Macedonia)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 7 Galafarm dooel Skopje: Competitive Position 2011

Replekpharm AD in Consumer Health (Macedonia)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

Adult Mouth Care in Macedonia - Category Analysis

HEADLINES

TRENDS

  • There was a growing consumer trend towards self-medicating mouth problems at the end of the review period, with this linked to a number of factors. Firstly, there was growing confidence in self-medication in general, with consumers becoming more confident in pharmacists’ recommendations for particular solutions or situations.

SWITCHES

COMPETITIVE LANDSCAPE

  • Apimell dooel was a clear leader in adult mouth care in 2011, accounting for a 26% value share. The company’s range is based on Macedonian propolis and herbs and offers an anaesthetic, anti-bacterial and anti-inflammatory effect. The company benefits from offering products that are viewed as safe and effective. The company also benefits from wide distribution and frequent pharmacist recommendations.

PROSPECTS

  • Adult mouth care is expected to continue to benefit from growing consumer confidence in self-medication over the forecast period. Many consumers will likely seek to ward off minor to moderate dental problems by using Apimell’s range, which is believed to be highly anti-bacterial. On-going economic uncertainty for many will also result in some consumers postponing dental visits, attempting to cope with tooth and gum pain by using adult mouth care products.

CATEGORY DATA

  • Table 11 Sales of Adult Mouth Care: Value 2006-2011
  • Table 12 Sales of Adult Mouth Care: % Value Growth 2006-2011
  • Table 13 Adult Mouth Care Company Shares 2007-2011
  • Table 14 Adult Mouth Care Brand Shares 2008-2011
  • Table 15 Forecast Sales of Adult Mouth Care: Value 2011-2016
  • Table 16 Forecast Sales of Adult Mouth Care: % Value Growth 2011-2016

Analgesics in Macedonia - Category Analysis

HEADLINES

TRENDS

  • Analgesics benefited from growing consumer confidence in self-medication towards the end of the review period. This confidence was partly due to general trends. Stronger media consumer health coverage and widening Internet access offered consumers more confidence in assessing their own symptoms, while a cumbersome medical system encouraged consumers to seek advice from pharmacists rather than doctors.

SWITCHES

COMPETITIVE LANDSCAPE

  • Alkaloid ad remains the dominant player in analgesics in 2011, accounting for a 56% value share in overall analgesics and 59% in systemic analgesics. This player benefits from its long presence in the country and from strong consumer trust. The company has an extensive distribution network and offers the well-established brands Caffetin and Analgin, which accounted for value shares of 35% and 17% respectively in systemic analgesics in 2011.

PROSPECTS

  • Analgesics is expected to see growth slow down as a result of the category’s increasing maturity, despite the growing trend in self-medication, yet it is expected to continue to grow with a 2% constant value CAGR over the forecast period. Growth will continue to be underpinned by continuous strong advertising of the leading brands, particularly Alkaloid’s Caffetin and Analgin brands, and the on-going growth in consumers’ confidence and their ability to self-medicate. The country’s predicted economic growth over the forecast period guarantees this, unless another major financial crisis spoils the prospects for the growth of analgesics.

CATEGORY DATA

  • Table 17 Sales of Analgesics by Category: Value 2006-2011
  • Table 18 Sales of Analgesics by Category: % Value Growth 2006-2011
  • Table 19 Analgesics Company Shares 2007-2011
  • Table 20 Analgesics Brand Shares 2008-2011
  • Table 21 Forecast Sales of Analgesics by Category: Value 2011-2016
  • Table 22 Forecast Sales of Analgesics by Category: % Value Growth 2011-2016

Calming and Sleeping in Macedonia - Category Analysis

HEADLINES

TRENDS

  • Benefiting greatly from stricter controls on under-the-counter sales of Rx calming and sleeping products over the review period, calming and sleeping products are gaining popularity. The government worked to prevent such sales, due to the abuse, misuse and potential health problems associated with Rx medication. Consequently, many consumers were forced to switch to OTC calming and sleeping products.

SWITCHES

COMPETITIVE LANDSCAPE

  • Lek dooel was a clear leader in 2011, accounting for a 45% value share. The company benefits from strong consumer awareness of its Persen brand, including its two different strength types. Unsurprisingly, its stronger variant, Persen Forte, proved particularly popular with those transitioning from Rx medicines towards the end of the review period as a result of stricter controls on under-the-counter sales. Lek dooel improved its position slightly in 2011 and added an impressive six percentage points compared with 2008.

PROSPECTS

  • Calming and sleeping products is expected to continue to benefit from stricter controls on Rx sales, however, with offending chemists/pharmacies likely to face fines or even closure. This will support a solid 5% constant value CAGR in calming and sleeping products over the forecast period. Forecast growth will also be supported by the growing consumer confidence in self-medication and a strong tradition of herbal/traditional products in the country.

CATEGORY DATA

  • Table 23 Sales of Calming and Sleeping: Value 2006-2011
  • Table 24 Sales of Calming and Sleeping: % Value Growth 2006-2011
  • Table 25 Calming and Sleeping Company Shares 2007-2011
  • Table 26 Calming and Sleeping Brand Shares 2008-2011
  • Table 27 Forecast Sales of Calming and Sleeping: Value 2011-2016
  • Table 28 Forecast Sales of Calming and Sleeping: % Value Growth 2011-2016

Cough, Cold and Allergy (Hay Fever) Remedies in Macedonia - Category Analysis

HEADLINES

TRENDS

  • Cough, cold and allergy (hay fever) remedies experienced strong growth amidst two long flu seasons and a prolonged allergy season in 2011. After the swine flu epidemic of 2009, which hit Macedonia hard, by March 2011, an estimated 25,000 people had been infected with this type of flu, resulting in six deaths in 2009 a and further 21 deaths over the 2010/2011 winter season. The extensive media coverage of the swine flu epidemic resulted in growing consumer awareness and focus on self-medication, prevention and use of cough and cold remedies to counter symptoms.

SWITCHES

COMPETITIVE LANDSCAPE

  • Krka Farma was the lead player in cough, cold and allergy (hay fever) remedies in 2011, accounting for a 23% value share. The company offers the well established brands Herbion in cough remedies and child-specific cough cold remedies and Septolete in cough remedies and pharyngeal preparations. The company however posted a minor value share loss in 2011 due to increased competition from other international competitors and combination products as well.

PROSPECTS

  • Macedonia’s problems with swine flu continued well into 2011, with six people dying of the disease in one week in March 2011. Consequently, the Macedonian media and population will continue to be strongly focused on the dangers of flu at the start of the forecast period. Consumers will become more likely to treat coughs and colds at the first signs of symptoms, thus hoping to avoid weakening their immune system and developing full-blown flu.

CATEGORY DATA

  • Table 29 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2006-2011
  • Table 30 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2006-2011
  • Table 31 Cough, Cold and Allergy (Hay Fever) Remedies Company Shares 2007-2011
  • Table 32 Cough, Cold and Allergy (Hay Fever) Remedies Brand Shares 2008-2011
  • Table 33 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2011-2016
  • Table 34 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2011-2016

Digestive Remedies in Macedonia - Category Analysis

HEADLINES

TRENDS

  • Consumers demonstrated growing confidence in diarrhoeal remedies and laxatives towards the end of the review period. Strong advertising for the leading brands Lek’s Linex and Krka’s Novolax within diarrhoeal remedies and laxatives respectively helped the growth of the digestive remedies category, driving growth in these areas. This gave consumers the confidence to increase self-medicating in response to the first signs of symptoms and their relief, rather than suffering the symptoms or seeking a doctor’s advice at a later stage.

SWITCHES

COMPETITIVE LANDSCAPE

  • Krka Farma was the leading player in digestive remedies in 2011 with a value share of 25%, followed by Lek with a 23% share. These players benefit from presence with strong brands, with Krka offering Novolax in laxatives and Rutacid in antacids and Lek offering Linex in diarrhoeal remedies. These brands continue to benefit from strong advertising support, with effective TV advertising in 2011 resulting in both players maintaining their leading positions and continuing to improve their value share over the previous year.

PROSPECTS

  • There are growing homeopathic and health and wellness trends in Macedonia, which are likely to continue hindering the sales of digestive remedies over the forecast period. Consumers are becoming increasingly aware of the benefits of a healthy diet and also more aware of the benefits of pro/pre biotic products, particularly yoghurt. Consequently, a growing focus on eating a healthy diet could well hinder sales growth for digestive remedies over the forecast period.

CATEGORY DATA

  • Table 35 Sales of Digestive Remedies by Category: Value 2006-2011
  • Table 36 Sales of Digestive Remedies by Category: % Value Growth 2006-2011
  • Table 37 Digestive Remedies Company Shares 2007-2011
  • Table 38 Digestive Remedies Brand Shares 2008-2011
  • Table 39 Forecast Sales of Digestive Remedies by Category: Value 2011-2016
  • Table 40 Forecast Sales of Digestive Remedies by Category: % Value Growth 2011-2016

Ear Care in Macedonia - Category Analysis

HEADLINES

TRENDS

  • Sales of ear care benefited from widening distribution at the end of the review period, with this in turn increasing availability and consumer awareness. The main instigator behind the push for wider distribution was Gradska Apteka, which managed to expand the reach of NaCl in the past several years of the review period as its chain of chemists/pharmacies expanded. This domestic brand is also priced at an affordable level, which encouraged many consumers to try ear care products for the first time.

SWITCHES

COMPETITIVE LANDSCAPE

  • Gradska Apteka was the clear leader in ear care in 2011, with the company accounting for a 23% value share. The company benefited from expanding distribution of its affordably-priced NaCl generic medicine across its own chain of pharmacies, with this chain also expanding towards the end of the review period.

PROSPECTS

  • Ear care is expected to benefit from increasing consumer awareness over the forecast period. Gradska Apteka is expected to continue to gain share for its NaCl generic, benefiting from wider distribution at more affordable prices. The brand is unlikely to see advertising support but may well benefit from word-of-mouth recommendations at the start of the forecast period, due to its low price and reasonable quality.

CATEGORY DATA

  • Table 41 Sales of Ear Care: Value 2006-2011
  • Table 42 Sales of Ear Care: % Value Growth 2006-2011
  • Table 43 Ear Care Company Shares 2007-2011
  • Table 44 Ear Care Brand Shares 2008-2011
  • Table 45 Forecast Sales of Ear Care: Value 2011-2016
  • Table 46 Forecast Sales of Ear Care: % Value Growth 2011-2016

Eye Care in Macedonia - Category Analysis

HEADLINES

TRENDS

  • 2011’s current value growth of the eye care category was 8% and begins to show signs of slowing down, particularly following the period of double-digit growth (when for example in 2008 and 2009 current value sales rose by 10% and 12% respectively). This growth has been linked to the widening retail availability and hence rising consumer awareness of products within the category. Chemists/pharmacies began to offer a wider range of eye care, with this resulting in strong sales.

SWITCHES

COMPETITIVE LANDSCAPE

  • Alkaloid ad was the dominant player in eye care at the end of the review period, accounting for a 58% value share. The company’s Proculin brand enjoys the widest possible distribution in eye care and is offered at relatively more affordable prices. This product has built its reputation over the past few decades and is the most recognisable eye care brand in Macedonia.

PROSPECTS

  • Eye care is expected to continue to benefit from changing consumer lifestyles over the forecast period such as increased computer and TV usage, which directly affect eye health. These trends are expected to become more pronounced as Macedonia’s economy continues to grow.

CATEGORY DATA

  • Table 47 Sales of Eye Care by Category: Value 2006-2011
  • Table 48 Sales of Eye Care by Category: % Value Growth 2006-2011
  • Table 49 Standard Eye Care by Format: % Value Breakdown 2007-2011
  • Table 50 Standard Eye Care by Positioning 2007-2011
  • Table 51 Eye Care Company Shares 2007-2011
  • Table 52 Eye Care Brand Shares 2008-2011
  • Table 53 Forecast Sales of Eye Care by Category: Value 2011-2016
  • Table 54 Forecast Sales of Eye Care by Category: % Value Growth 2011-2016

Herbal/Traditional Products in Macedonia - Category Analysis

HEADLINES

TRENDS

  • 2011 saw current value growth of 11% over the previous year, which was markedly below the 15% current value CAGR seen over the review period as a whole. Growth slowed down slightly with the moderate decline seen across most herbal/traditional products, but only relative to the growth levels over the review period. Otherwise, all growth levels for 2011 were relatively strong.

COMPETITIVE LANDSCAPE

  • Alkaloid ad led sales of herbal/traditional products in Macedonia with an 8% value share in 2011, improving its position relative to previous year. Krka Farma’s Herbion with 5%, Fitopharm doo’s Valeriana and Alkaloid’s UVE Mix each held a value share of around 4%, representing the leading brands within the herbal/traditional product category in Macedonia. These value shares indicate a high level of fragmentation of the products in this category. Finally, Krka Farma Co ranked second with a 7% value share in the overall herbal/traditional products category in 2011.

PROSPECTS

  • The forecast period is expected to see a constant value growth with a CAGR of 6%, compared with the corresponding review period CAGR of over 11%. The review period saw a surge in OTC herbal/traditional products, with chemists/pharmacies and parapharmacies/drugstores increasingly offering a range of herbal/traditional topical analgesics/anaesthetic, cough, cold and allergy (hay fever) remedies and digestive remedies.

CATEGORY DATA

  • Table 55 Sales of Herbal/Traditional Products: Value 2006-2011
  • Table 56 Sales of Herbal/Traditional Products: % Value Growth 2006-2011
  • Table 57 Herbal/Traditional Products Company Shares 2007-2011
  • Table 58 Herbal/Traditional Products Brand Shares 2008-2011
  • Table 59 Forecast Sales of Herbal/Traditional Products: Value 2011-2016
  • Table 60 Forecast Sales of Herbal/Traditional Products: % Value Growth 2011-2016

Medicated Skin Care in Macedonia - Category Analysis

HEADLINES

TRENDS

  • Self-medication not only gained popularity as a means of avoiding time- and money consuming doctor’s visits over the review period, but there was also a growing trend towards self-medicating involving more embarrassing ailments such as vaginal fungal infections and lice, rather than seeking doctor’s advice. This trend was particularly encouraged by strong advertising for vaginal antifungal brands Betadine and Kantarion, from Alkaloid and Fitopharm respectively.

SWITCHES

COMPETITIVE LANDSCAPE

  • Fitopharm doo was the clear leader in medicated skin care in 2011, accounting for a value share of 24%. The company benefits from offering a range of brands, including Kantarion in vaginal antifungals, Losion and Klimicin in acne treatments and Herpesan in cold sore treatments. The company supported Kantarion, Losion and Klimicin with strong advertising towards the end of the review period. Effective promotional support thus resulted in Fitopharm doo seeing the strongest growth in value share in 2011 over the previous year, with the company gaining nearly half a percentage point.

PROSPECTS

  • Sales of medicated skin care are expected to be constrained by strong competition from beauty and personal care over the forecast period. Acne treatments and medicated shampoos are particularly likely to suffer, with cosmetic brands benefiting from stronger branding and marketing support. Cosmetic brands also typically offer lower prices and are thus likely to attract a wider consumer base compared with medicated skin care.

CATEGORY DATA

  • Table 61 Sales of Medicated Skin Care by Category: Value 2006-2011
  • Table 62 Sales of Medicated Skin Care by Category: % Value Growth 2006-2011
  • Table 63 Medicated Skin Care Company Shares by Value 2007-2011
  • Table 64 Medicated Skin Care Brand Shares 2008-2011
  • Table 65 Forecast Sales of Medicated Skin Care by Category: Value 2011-2016
  • Table 66 Forecast Sales of Medicated Skin Care by Category: % Value Growth 2011-2016

Sports Nutrition in Macedonia - Category Analysis

HEADLINES

TRENDS

  • Sports nutrition has a limited consumer base in Macedonia, with most consumers having little awareness of these products. Sales are largely limited to young male professional or semi-professional athletes and body builders. Most consumers remain wary of sports nutrition, associating these products with steroids. This lack of consumer awareness and limited interest continued to constrain sales of sports nutrition products at the end of the review period.

COMPETITIVE LANDSCAPE

  • Sales of sports nutrition remained highly fragmented at the end of the review period, with no apparent leader in the category. Sales are dominated by imports, with these accounting for an estimated 95% of value sales in 2011.

PROSPECTS

  • Sports nutrition is expected to see a 9% constant value CAGR over the forecast period, which represents an improvement from the 7% constant value CAGR seen over the review period. The increased growth is due to the increased interest and demand for sports nutrition products coupled with increasing levels of consumer awareness and improved distribution of sports nutrition products.

CATEGORY DATA

  • Table 67 Sales of Sports Nutrition: Value 2006-2011
  • Table 68 Sales of Sports Nutrition: % Value Growth 2006-2011
  • Table 69 Forecast Sales of Sports Nutrition: Value 2011-2016
  • Table 70 Forecast Sales of Sports Nutrition: % Value Growth 2011-2016

Vitamins and Dietary Supplements in Macedonia - Category Analysis

HEADLINES

TRENDS

  • Vitamins and dietary supplements benefited strongly from the growing health and wellness trend in Macedonia over the review period. Consumers are becoming increasingly aware of the nutritional values and benefits offered by the various vitamins and dietary supplements. Strong advertising for vitamins and dietary supplements brands such as Wyeth’s Centrum, Kendy Suisse AG’s Supravit and Galenika’s Oligovit also resulted in growing consumer interest in this product area in 2011.

VITAMINS

DIETARY SUPPLEMENTS

COMPETITIVE LANDSCAPE

  • Krka Farma led sales of vitamins and dietary supplements with a 24% value share in 2011, improving its position slightly relative to 2010. Krka Farma’s B-Complex and Pikovit top the list of best selling brands within the vitamins and dietary supplements category, holding 9% and 8% value shares respectively.

PROSPECTS

  • The vitamins and dietary supplements environment is expected to see considerably slower growth at a CAGR of 3% over the forecast period – lower than the review period constant value CAGR of 4%. The growth of the category is expected to slow down due to a limited consumer base for these products, with sales continuing to be limited mainly to mid- to high-income urban consumers with a strong interest in health. Many consumers will continue to have little interest in purchasing vitamins and dietary supplements, choosing healthy diet as better and more affordable alternative.

CATEGORY DATA

  • Table 71 Sales of Vitamins and Dietary Supplements by Category: Value 2006-2011
  • Table 72 Sales of Vitamins and Dietary Supplements by Category: % Value Growth 2006-2011
  • Table 73 Dietary Supplements by Positioning 2007-2011
  • Table 74 Vitamins and Dietary Supplements Company Shares 2007-2011
  • Table 75 Vitamins and Dietary Supplements Brand Shares 2008-2011
  • Table 76 Vitamins Brand Shares 2008-2011
  • Table 77 Dietary Supplements Brand Shares 2008-2011
  • Table 78 Forecast Sales of Vitamins and Dietary Supplements by Category: Value 2011-2016
  • Table 79 Forecast Sales of Vitamins and Dietary Supplements by Category: % Value Growth 2011-2016
  • Summary 10 Dietary Supplements: Brand Ranking by Positioning 2011

Weight Management in Macedonia - Category Analysis

HEADLINES

TRENDS

  • There was a trend of increased awareness of the dangers of excess weight over the review period, with consumers becoming more aware of the links between excess weight and problems such as diabetes and heart health. This trend was most pronounced among urban consumers below the age of 40. Many consumers, however, remain unaware or uninterested in weight management products, either due to their lack of availability or high unit prices.

COMPETITIVE LANDSCAPE

  • Vitalia Nikola doo led sales of weight management in 2011, accounting for an 18% value share. This company benefits from offering a wide range of weight management products and from its wide distribution network. Vitalia Nikola doo was the leading player in weight loss supplements in 2011 with a 19% value share. The company meanwhile ranked second in meal replacement slimming with a 17% value share, and was second in slimming teas with 23%.

PROSPECTS

  • Over the forecast period, weight management is expected to see a constant value CAGR of 5% compared with a corresponding review period CAGR of 2% Weight management is expected to benefit from a growing focus on weight over the forecast period. The government is increasingly recognising the cost of the country’s weight problems, due to associated health problems, and is thus likely to invest in consumer education campaigns over the forecast period.

CATEGORY DATA

  • Table 80 Sales of Weight Management by Category: Value 2006-2011
  • Table 81 Sales of Weight Management by Category: % Value Growth 2006-2011
  • Table 82 Weight Management Company Shares 2007-2011
  • Table 83 Weight Management Brand Shares 2008-2011
  • Table 84 Forecast Sales of Weight Management by Category: Value 2011-2016
  • Table 85 Forecast Sales of Weight Management by Category: % Value Growth 2011-2016

Wound Care in Macedonia - Category Analysis

HEADLINES

TRENDS

  • The wound care environment benefited from improved and wider distribution of wound care products towards the end of the review period, with these products gaining an increasing distribution presence through supermarkets and hypermarkets as well as “other” grocery retailers.

COMPETITIVE LANDSCAPE

  • Shifts in share in wound care were largely linked to distribution presence at the end of the review period. Tosama remained the leading player in 2011, accounting for an 18% value share thanks to its strong distribution via both the supermarkets/hypermarkets and chemists/pharmacies channels. The company increased its value share by half a percentage point mainly due to stronger presence in the grocery retailers distribution channel.

PROSPECTS

  • There is expected to be an on-going shift to non-specialist distribution channels for wound care over the forecast period. Supermarkets/hypermarkets and “other” grocery retailers are expected to continue to gain share, with consumers increasingly picking these products up alongside their regular grocery shopping.

CATEGORY DATA

  • Table 86 Sales of Wound Care by Category: Value 2006-2011
  • Table 87 Sales of Wound Care by Category: % Value Growth 2006-2011
  • Table 88 Wound Care Company Shares 2007-2011
  • Table 89 Wound Care Brand Shares 2008-2011
  • Table 90 Forecast Sales of Wound Care by Category: Value 2011-2016
  • Table 91 Forecast Sales of Wound Care by Category: % Value Growth 2011-2016

Segmentation

Segmentation

This market research report includes the following:

  • Consumer Health
    • OTC
      • Adult Mouth Care
      • Analgesics
        • Systemic Analgesics
          • Adult Analgesics
            • Acetaminophen
            • Aspirin
            • Combination Products - Analgesics
            • Diclofenac
            • Dipyrone
            • Ibuprofen
            • Ketoprofen
            • Naproxen
          • Paediatric Analgesics
            • Paediatric Acetaminophen
            • Paediatric Aspirin
            • Paediatric Combination Products - Analgesics
            • Paediatric Diclofenac
            • Paediatric Dipyrone
            • Paediatric Ibuprofen
            • Paediatric Ketoprofen
            • Paediatric Naproxen
        • Topical Analgesics/Anaesthetic
      • Calming and Sleeping
      • Cough, Cold and Allergy (Hay Fever) Remedies
        • Antihistamines/Allergy Remedies (Systemic)
        • Paediatric Cough, Cold and Allergy Remedies
          • Paediatric Allergy Remedies
          • Paediatric Cough/Cold Remedies
        • Combination Products - Cough, Cold and Allergy (Hay Fever) Remedies
        • Cough Remedies
        • Decongestants
          • Nasal Sprays
          • Oral Decongestants
          • Inhalant Decongestants
          • Decongestant Rubs
          • Nasal Decongestant Drops
          • Nasal Decongestant Plasters
        • Medicated Confectionery
        • Pharyngeal Preparations
      • Digestive Remedies
        • Paediatric Digestive Remedies
          • Paediatric Diarrhoeal Remedies
          • Paediatric Indigestion and Heartburn Remedies
          • Paediatric Laxatives
          • Paediatric Motion Sickness Remedies
        • Diarrhoeal Remedies
        • IBS Treatments
        • Indigestion and Heartburn Remedies
          • Antacids
          • Antiflatulents
          • Digestive Enzymes
          • H2 Blockers
          • Proton Pump Inhibitors
        • Laxatives
        • Motion Sickness Remedies
      • Ear Care
      • Emergency Contraception
      • Eye Care
        • Allergy Eye Care
        • Standard Eye Care
      • Medicated Skin Care
        • Medicated Shampoos
        • Topical Antifungals
        • Vaginal Antifungals
        • Hair Loss Treatments
        • Nappy (Diaper) Rash Treatments
        • Antiparasitics/Lice (Head and Body) Treatments
        • Antipruritics
        • Paediatric Medicated Skin Care
        • Cold Sore Treatments
        • Haemorrhoid Treatments
        • Topical Allergy Remedies/Antihistamines
        • Topical Germicidals/Antiseptics
      • NRT Smoking Cessation Aids
        • NRT Gum
        • NRT Inhalators
        • NRT Lozenges
        • NRT Patches
        • Other NRT
      • OTC Triptans
      • Wound Care
        • First Aid Kits
        • Sticking Plasters/Adhesive Bandages
        • Gauze, Tape and Other Wound Care
    • Sports Nutrition
      • Protein Products
        • Bars
        • Powder
        • RTD
        • Other Protein
      • Non-Protein Products
    • Vitamins and Dietary Supplements
      • Paediatric Vitamins and Dietary Supplements
      • Dietary Supplements
        • Combination Dietary Supplements
        • Herbal/Traditional Dietary Supplements
          • Combination Herbal/Traditional Dietary Supplements
          • Echinacea
          • Evening Primrose Oil
          • Garlic
          • Ginkgo Biloba
          • Ginseng
          • St John's Wort
          • Other Herbal/Traditional Dietary Supplements
          • Non-Herbal Dietary Supplements
            • Calcium Supplements
            • Co-Enzyme Q10
            • Combination Non-Herbal Dietary Supplements
            • Eye Health Supplements
            • Fish Oils
              • Cod Liver Oil
              • Other Fish Oils
            • Glucosamine
            • Mineral Supplements
            • Omega-3-6-9 (Fish and Non-Fish)
            • Probiotic Supplements
            • Protein Powder
            • Royal Jelly
            • Sam-E
            • Other Non-Herbal Dietary Supplements
          • Tonics and Bottled Nutritive Drinks
          • Vitamins
            • Multivitamins
            • Single Vitamins
              • Vitamin A
              • Vitamin B
              • Vitamin C
              • Vitamin D
              • Vitamin E
              • Other Single Vitamins
        • Weight Management
          • Meal Replacement Slimming
          • OTC Obesity
          • Slimming Teas
          • Weight Loss Supplements
          • Other Slimming Products
        • Herbal/Traditional Products
          • Herbal/Traditional Analgesics
          • Herbal/Traditional Calming and Sleeping Products
          • Herbal/Traditional Cough, Cold and Allergy (Hay Fever) Remedies
          • Herbal/Traditional Digestive Remedies
          • Herbal/Traditional Medicated Skin Care
          • Herbal/Traditional Medicinal Teas
          • Herbal/Traditional Smoking Cessation Aids
          • Herbal/Traditional Paediatric Dietary Supplements
          • Herbal/Traditional Dietary Supplements
          • Herbal/Traditional Tonics and Bottled Nutritive Drinks
        • Allergy Care
          • Allergy Eye Care
          • Antihistamines/Allergy Remedies (Systemic)
          • Paediatric Allergy Remedies
          • Topical Allergy Remedies/Antihistamines
        • Paediatric Consumer Health
          • Paediatric Analgesics
            • Paediatric Acetaminophen
            • Paediatric Aspirin
            • Paediatric Combination Products - Analgesics
            • Paediatric Diclofenac
            • Paediatric Dipyrone
            • Paediatric Ibuprofen
            • Paediatric Ketoprofen
            • Paediatric Naproxen
          • Paediatric Cough, Cold and Allergy Remedies
            • Paediatric Allergy Remedies
            • Paediatric Cough/Cold Remedies
          • Paediatric Digestive Remedies
            • Paediatric Diarrhoeal Remedies
            • Paediatric Indigestion and Heartburn Remedies
            • Paediatric Laxatives
            • Paediatric Motion Sickness Remedies
          • Paediatric Medicated Skin Care
          • Nappy (Diaper) Rash Treatments
          • Paediatric Vitamins and Dietary Supplements

      Statistics Included

      Statistics Included

      For each category and subcategory you will receive the following data in Excel format:

      From Passport

      • Market sizes
      • Company shares
      • Brand shares
      • Distribution
      • Analysis by format
      • Analysis by positioning
      • Herbal/traditional vs standard
      • Pricing
      • Smoking population - number of adult smokers
      • Smoking prevalence - % of adult population

      Market size details:

      • Retail volume
      • Retail volume % growth
      • Retail volume per capita
      • Retail value retail selling price % growth
      • Retail value retail selling price local currency, USD, EUR, GBP, CHF, JPY
      • Retail value retail selling price per capita local currency, USD, EUR, GBP, CHF, JPY
      • Retail value manufacturer selling price % growth
      • Retail value manufacturer selling price local currency, USD, EUR, GBP, CHF, JPY
      • Retail value manufacturer selling price per capita local currency, USD, EUR, GBP, CHF, JPY

      Methodology

      Methodology

      Global insight and local knowledge

      With 40 years’ experience of developed and emerging markets, Euromonitor International’s research method is built on a unique combination of specialist industry knowledge and in-country research expertise.

      This approach is what enables us to achieve our goal of building a market consensus view of size, shape and trends across the full distribution universe of each category. We factor in whichever channels are relevant, from large-scale grocery to direct sellers, from discount stores to local mom-and-pop outlets.

      Industry specialists

      Each industry we cover is managed by an Industry Manager and team of Industry Analysts who research and report on their specialist categories all year round.

      Our collaborative approach to research means that these industry teams are in constant dialogue with industry players and opinion formers. The planning of our research programmes reflects latest market trends and industry events. In completing each update project, this provides invaluable input to the testing, review and finalisation of our data.

      The specialist in-house teams bring together findings from all stages of the annual research process. They work closely with in-country analysts, assess and challenge data and exercise final editorial control over the publication of new data and analysis.

      Country and regional analysts

      Our in-country analyst network is managed by country and regional analysts in our offices around the world. Working closely with each in-country team, the regional research management team ensures that all country researchers are well schooled in best practices, from the information collected in store checks, to the dialogue we build in trade surveys. Our country analysts ensure that national reports explain the data trends and provide clear insights into the local market’s dynamics.

      In-country research network

      To deliver fresh insights every year in countries all around the world, we believe the strongest approach is to use analysts on the ground. They bring fluency in local language, physical proximity to the best sources, an ability to engage directly with local industry contacts, and an awareness of how the products and services we study are advertised, sold and consumed. These are essential parts of our ability to report incisively on these markets.

      Research Methodology

      Our research methods

      Each Euromonitor International industry report is based on a core set of research techniques:

      Desk research

      With industry events, corporate activity, trends and new product introductions tracked year round by our industry team, desk research provides a starting point for the in-country research programme. Our in-country researchers will access the following sources:

      • National statistics offices governmental and official sources
      • National and international trade press
      • National and international trade associations
      • Industry study groups and other semi-official sources
      • Company financials and annual reports
      • Broker reports
      • Online databases
      • The financial, business and mainstream press

      Accessing sources is only the first step. The ability to interpret and reconcile often conflicting information across multiple sources is a key aspect of the added value we provide.

      Store checks

      Store checks are an integral part of our methods for product industries. Carried out on the ground across a relevant mix of channels, the information gained provides first-hand insights into the products we are researching, specifically:

      • Place: We track products in all relevant channels, selective and mass, store and non-store
      • Product: What are innovations in products, pack sizes and formats?
      • Price: What are brand price variations across channels, how do private label’s prices compare to those of branded goods?
      • Promotion: What are marketing and merchandising trends, offers, discounts and tie-ins?

      Findings are cross-referenced with brand share data analysis. The results, combined with the findings of desk research, provide a strong basis for identifying key areas of questioning to take forward into our trade survey.

      Trade survey

      Interaction with global players at corporate HQ and regional levels is complemented by unique local data and insights from our in-country trade surveys around the world. Through the high profile of the Euromonitor International brand, we are able to talk directly to a wide range of sources and therefore inform our analysis with the knowledge and opinions of the leading operators in the market.

      Trade surveys allow us to:

      • Fill gaps in available published data per company
      • Generate a consensus view of the size, structure and strategic direction of the category
      • Access year-in-progress data where published sources are out of date
      • Evaluate the experts’ views on current trends and market developments

      In building our composite industry view, we engage with a variety of personnel in key players at all points of the supply chain: materials suppliers, manufacturers, distributors, retailers and service operators. We also interview desk research sources: industry associations; study groups; and third party observers from the trade and financial press.

      Our objective is to engage in conversation with trade sources in which we exchange ideas and views on the industry, sharing our work-in-progress findings on supply/demand dynamics and potential. This dialogue enhances both parties’ understanding of the local market. The scope and reach of our trade survey also serves to eliminate bias (intentional and unintentional) from any single source.

      Company analysis

      At a global level, our company research combines our mix of industry interaction and use of secondary sources such as annual accounts, broker reports, financial press and databases. From a data perspective, the aim is to build “top-down” estimates of major players’ total global and regional sales.

      At a country level, in line with local reporting requirements, we access annual accounts, national-specific company databases and local company websites. These are all invaluable sources as we build a view of each domestic player’s size and position within very specific categories of the industry.

      Forecasts

      Data projections and future performance analysis are key elements of Euromonitor International’s market intelligence. Working with historic trends of 15 years or more, a key aspect of our trade survey is to engage industry insider views of the next five years. Will volumes maintain their historic trend? Will price increases or falls of recent years continue, accelerate or slow down? Will increasing demand for one product cannibalise sales of another?

      Forecasts represent many of the essential conclusions we have reached about the current state of the market, how it works and how it behaves under different macro and micro conditions. Our written analysis will state the assumptions and the trade opinion behind whether our predictions are optimistic or pessimistic, so that clients can use our statistical forecasts with confidence.

      Data validation

      All data is subjected to an exhaustive review process, at country, regional and global levels.

      The interpretation and review of sources and data inputs forms a central part of the collaboration between industry teams and country researchers. Numbers are delivered to regional and global offices with an audit trail of sources and calculations to allow for a thorough evaluation of data sense and integrity.

      Upon completion of the country review phase, data is then reviewed on a comparative basis at regional and then at a global level. Comparative checks are carried out on per capita consumption and spending levels, growth rates, patterns of category and subcategory breakdowns and distribution of sales by channel. Top-down estimates are reviewed against bottom-up regional and global market and company sales totals.

      Where marked differences are seen between proximate country markets or ones at similar developmental levels, supplementary research is conducted in the relevant countries to confirm and/or amend those findings. This process ensures international comparability across the database, that consistent category and subcategory definitions have been used and that all data has been correctly tested. We make sure that possible discrepancies between different published sources have been reconciled and that our interpretation of opinion and expectation from each country’s trade sources has been applied to form a coherent international pattern.

      Market analysis

      Another integral part of all our research programmes is that all Euromonitor International data is accompanied by clear written analysis. From a research perspective, this explains and substantiates data findings. From a client perspective, this offers unique insights into local consumption trends, routes to market, brand preferences, channel dynamics and future trends.

      Our country level analysis also provides invaluable input into the ability of our central industry specialist teams to marry local insights with strategic conclusions on the direction of the market regionally and globally.

      my pages

      Want to find out more about this report?

      If you purchase a report that is updated in the next 60 days, we will send you the new edition of the report and the data extract FREE!